| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Craig Jonathan Gulliford CEO | LSE Exchange | G253HH102 CUSIP |
| GB Country | 104 Employees | - Last Dividend | - Last Split | - IPO Date |
Creo Medical Group PLC, founded in 2003 and headquartered in Chepstow, the United Kingdom, operates as a pioneering entity within the medical devices sector. The company is engaged in the rigorous research, development, manufacture, and sales of advanced medical devices and instruments, catering primarily to the UK market. At the heart of Creo Medical Group's innovation is the development of CROMA, an avant-garde energy platform that adeptly combines bipolar radiofrequency with microwave energy. This combination not only facilitates precise and localized cutting but also ensures controlled coagulation. The primary objective of this technology is to equip physicians with tools that are both highly controllable and accurate, delivered through the convenience of a flexible endoscope.
An innovative energy multimodal instrument designed for flexible endoscopy, offering a blend of precision and versatility in treatment applications.
A microwave needle ablation device, introducing an efficient solution for the focused ablation of soft tissues with minimal invasiveness.
A flexible microwave ablation device tailored for the effective ablation of soft tissues, enhancing procedural flexibility and patient outcomes.
A flexible haemostasis device specifically designed to address the challenges of treating upper and lower gastrointestinal (GI) bleeds, marking a significant advancement in GI care.
A unique flexible bipolar RF and microwave scissor device engineered for the precise grasping, cutting, and coagulation of highly perfused tissues, setting new standards in surgical precision.